Nidan Laboratories And Healthcare Ltd.
NSE: NIDAN
₹14.55
₹0.00 (0.00%)As on 27-May-2026IST
Market cap
₹20 Cr
Revenue (TTM)
₹25 Cr
P/E Ratio
13.4
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹2 Cr
-
ROE
2.9 %
-
ROCE
6.2 %
-
Industry P/E
56.08
-
EV/EBITDA
4.4
-
Debt to Equity
0.2
-
Book Value
₹49.1
-
EPS
₹1.4
-
Face value
10
-
Shares outstanding
13,900,000
7 Years Aggregate
CFO
₹44.50 Cr
EBITDA
₹52.09 Cr
Net Profit
₹8.19 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nidan Laboratories
| -22.0 | -6.7 | -16.9 | -23.8 | -29.9 | -- | -- |
|
BSE Healthcare
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Nidan Laboratories
| -36.0 | -13.8 | -30.8 | -6.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Nidan Laboratories
|
14.6 | 20.2 | 24.5 | 2.0 | -- | 2.9 | 13.4 | 0.3 |
| 1,617.2 | 27,125.5 | 2,762.9 | 509.8 | 22.5 | 21.5 | 53.7 | 10.8 | |
| 784.5 | 31,398.9 | 3,904.6 | 239.4 | 13.3 | 11.1 | 130.1 | 14.0 | |
| 538.5 | 1,749.1 | 772.8 | 101.5 | 15.7 | 10.7 | 17.2 | 1.8 | |
| 536.2 | 11,144.1 | 1,645.9 | 191.2 | 16.2 | 13.3 | 58.6 | 7.4 | |
| 605.1 | 6,080.7 | 755.8 | 67.1 | -- | 13.8 | 79.1 | 5.4 | |
| 311.6 | 973.9 | 1,231.3 | 29.1 | -4.7 | 4 | 37.4 | 1.4 | |
| 289.6 | 1,498.9 | 310.4 | 31.4 | 17.4 | 13.5 | 46.6 | 6.1 | |
| 512.2 | 8,154.8 | 829.0 | 161.5 | 24.5 | 30 | 50 | 13.9 | |
| 1,261.4 | 12,976.8 | 814.2 | 173.0 | 30.1 | 19 | 75 | 13.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Nidan Laboratories
Hospital activities
-
Incorporated
2000
-
Chairman
--
-
Managing Director
--
-
Headquarters
Palghar, Maharashtra
-
Website
Looking for more details about Nidan Laboratories And Healthcare Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Nidan Laboratories
What is the current share price of Nidan Laboratories And Healthcare Ltd Today?
The share price of Nidan Laboratories And Healthcare Ltd is ₹14.55 (NSE) as of 27-May-2026 IST. Nidan Laboratories And Healthcare Ltd has given a return of -29.85% in the last 3 years.
What is the current PB & PE ratio of Nidan Laboratories And Healthcare Ltd?
The P/E ratio of Nidan Laboratories And Healthcare Ltd is 13.43 times as on 27-May-2026, a 76 discount to its peers’ median range of 56.08 times.
The P/B ratio of Nidan Laboratories And Healthcare Ltd is 0.30 times as on 27-May-2026, a 96 discount to its peers’ median range of 7.78 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
11.64
|
0.34
|
|
2024
|
0.00
|
0.57
|
|
2023
|
13.29
|
0.68
|
|
2022
|
17.33
|
0.70
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Nidan Laboratories And Healthcare Ltd?
The 52-week high and low of Nidan Laboratories And Healthcare Ltd are Rs 24.90 and Rs 12.75 as of 28-May-2026.
What is the market cap of Nidan Laboratories And Healthcare Ltd?
Nidan Laboratories And Healthcare Ltd has a market capitalisation of ₹ 20 Cr as on 27-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Nidan Laboratories And Healthcare Ltd?
Before investing in Nidan Laboratories And Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.